Sharon Bio-Medicine standalone net profit declines 16.58% in the March 2022 quarter

Sales rise 8.16% to Rs 48.53 crore

Net profit of Sharon Bio-Medicine declined 16.58% to Rs 4.68 crore in the quarter ended March 2022 as against Rs 5.61 crore during the previous quarter ended March 2021. Sales rose 8.16% to Rs 48.53 crore in the quarter ended March 2022 as against Rs 44.87 crore during the previous quarter ended March 2021.

For the full year,net profit rose 25.77% to Rs 17.67 crore in the year ended March 2022 as against Rs 14.05 crore during the previous year ended March 2021. Sales rose 11.92% to Rs 184.53 crore in the year ended March 2022 as against Rs 164.88 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales48.5344.87 8 184.53164.88 12 OPM %13.1314.40 -14.2013.11 - PBDT7.488.50 -12 28.9025.56 13 PBT4.685.61 -17 17.6714.05 26 NP4.685.61 -17 17.6714.05 26

Powered by Capital Market - Live News